Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000477560 | SCV000544440 | benign | Tuberous sclerosis 2 | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002255385 | SCV000847722 | likely benign | Hereditary cancer-predisposing syndrome | 2020-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000477560 | SCV002041362 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255385 | SCV002530977 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-01-24 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV004000705 | SCV004819292 | likely benign | Tuberous sclerosis syndrome | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000477560 | SCV005406080 | likely benign | Tuberous sclerosis 2 | 2024-08-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |